Identification of Stem-Like Cells in Atrial Myxoma by Markers CD44, CD19, and CD45

<div>Characterization of subcultured myxoma cells from atrial myxoma. (a) After a period ranging from 1 to 3 weeks, phase-bright (arrow head) cells migrated over a layer of fibroblast-like cells (I, II). The phase-bright cells were collected, and Giemsa stain showed the cell with a large nucleus (III). Scale bar = 100 <i>μ</i>m (I &amp; II), =4 <i>μ</i>m (III). (b) Quantification by FACS analysis of myxoma derived phase-bright cells. This cell population expresses robust CD44, CD19, and CD45.</div>

Stem Cells International

fig2

Figure 2

Figure 2: Identification of Stem-Like Cells in Atrial Myxoma by Markers CD44, CD19, and CD45 